The drug for preventing and treating colds and flu :: Consumers survey results of for 2 quarter of 2016

Consumers survey results of for 2 quarter of 2016 in category

Antiviral medications / The drug for preventing and treating colds and flu

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Amizon (Farmak)	29.17%	5

1.	2	Афлубін (Perrigo)	29.17%	5

3.	2	Аміксин IC (InterChem)	20.83%	3.57

4.		Колдрекс (GlaxoSmithKline)	16.67%	2.86

4.	6	Терафлю (Novartis OTC)	16.67%	2.86

6.	4	Амброксол (Ternopharm)	12.50%	2.14

6.	1	Анаферон (Materia Medica – Ukraine)	12.50%	2.14

6.	~	Енгістол (Heel)	12.50%	2.14

6.	4	Оксолінова мазь (Nizhpharm)	12.50%	2.14

10.	3	Gripex (Delta Medical)	8.33%	1.43

10.	6	Грип-Хеель (Heel)	8.33%	1.43

10.	4	Гропринозин (Gedeon Richter)	8.33%	1.43

10.	~	Лавомакс (Nizhpharm)	8.33%	1.43

10.	6	Пертуссин (Ternopharm)	8.33%	1.43

10.	2	Фервекс (Bristol-Myers Squibb)	8.33%	1.43

10.	5	Хелпекс (Movi Health GmbH)	8.33%	1.43

17.	3	Arbidol (OTC-Фарм)	4.17%	0.71

17.	4	Bioparox (Les Laboratoires Servier)	4.17%	0.71

17.	6	Іммустат (Darnitsa)	4.17%	0.71

17.	6	Антигрипін (Національна гомеопатична спілка)	4.17%	0.71

17.	~	Грипго (Gledpharm)	4.17%	0.71

17.	5	Ехінацея-Фаркос (Фаркос)	4.17%	0.71

17.	~	Краплі від грипу др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	4.17%	0.71

17.	6	Лаферон – ФармБіотек Назальний (Interpharmbiotek)	4.17%	0.71

17.	6	Ремавір (Олайнфарм)	4.17%	0.71

17.	~	Ремантадин-КР (Red star)	4.17%	0.71

17.	5	Солодки корня сироп (Ternopharm)	4.17%	0.71

–.		Ergoferon (Materia Medica – Ukraine)	0.00%	0

–.	5	Immunoflazid (Ecofarm)	0.00%	0

–.	3	Influcid (DHU)	0.00%	0

–.	2	Viferon (Feron)	0.00%	0

–.		Адріанол (Actavis)	0.00%	0

–.	6	Альтабор (Борщагівський ХФЗ)	0.00%	0

–.		Кагоцел (Ніармедик Плюс)	0.00%	0

–.		Колд-ікс	0.00%	0

–.		Лекадол плюс C (Sandoz)	0.00%	0

–.	5	Мукалитан (Ternopharm)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2016, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.